In broader terms, these data showing the consistency with which gene expression effects are observed in these genetically modified mouse models of prostate cancer also highlights the very limited understanding of how, and with what effects, these many gene expression changes are driven by loss of the PTEN tumour suppressor. The gene discussed is PTEN; the disease is prostate cancer.